Duality Advisers, LP Becton Dickinson & CO Transaction History

Duality Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$232.24 - $267.23 $680,927 - $783,518	2,932 New	2,932 $714,000
Q3 2022 Nov 03, 2022	BUY	$51.03 - $264.23 $1.21 Million - $6.25 Million	23,647 New	23,647 $5.27 Million
Q2 2022 Aug 08, 2022	SELL	$234.74 - $275.42 $1.81 Million - $2.13 Million	-7,729 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$243.64 - $270.48 $2.1 Million - $2.33 Million	-8,629 Reduced 52.75%	7,729 $2.06 Million
Q4 2021 Feb 02, 2022	BUY	$230.08 - $250.94 $3.76 Million - $4.1 Million	16,358 New	16,358 $4.11 Million
Q2 2021 Aug 09, 2021	SELL	$232.65 - $254.58 $5.58 Million - $6.11 Million	-23,988 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $5.57 Million - $6.16 Million	23,988 New	23,988 $5.83 Million
Q4 2020 Feb 09, 2021	SELL	$221.92 - $245.94 $2.35 Million - $2.61 Million	-10,610 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $1.94 Million - $2.49 Million	9,009 Added 562.71%	10,610 $2.47 Million
Q2 2020 Jul 29, 2020	BUY	$219.9 - $263.41 $352,059 - $421,719	1,601 New	1,601 $373,000
Q4 2019 Feb 10, 2020	SELL	$236.45 - $266.82 $1.97 Million - $2.22 Million	-8,320 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$230.58 - $256.08 $1.92 Million - $2.13 Million	8,320 New	8,320 $2.11 Million
Q2 2019 Aug 12, 2019	SELL	$217.4 - $246.08 $3.8 Million - $4.3 Million	-17,480 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$206.05 - $248.17 $405,918 - $488,894	1,970 Added 12.7%	17,480 $4.37 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $3.18 Million - $4 Million	15,510 New	15,510 $3.5 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.